Smart Quotes
Remus Pharmaceuticals Ltd.
BSE CODE:   |   NSE CODE: NA   |   ISIN CODE : INE0O5T01011
BSE NSE
0.00
0 ( 0% )
 
Prev Close ( Rs.)
NA
Open ( Rs.)
0.00
 
High ( Rs.)
0.00
Low ( Rs.)
0.00
 
Volume
0
Week Avg.Volume
NA
 
52 WK High-Low Range (Rs.)
BSE NSE
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range (Rs.)
1D   | 1M   | 3M   | 1Y  | 3Y  | 5Y
F&O Quote of TATASTEEL
Instrument Type Expiry Date Option Type Strike Price
  QUOTES  
Rs.108.85    0.00 (0.00 %)
Open (Rs.) 106.90
Prev Close (Rs.) 108.85
High (Rs.) 109.15
Low (Rs.) 106.90
Average Price Rs. 108.32
Contracts Traded 12259
Turnover (Rs.Lakhs) 73034
Open Interest  213785000.00
Open Int. Chg  0.00
Open Int. Chg(%) 0.00
Competitors
Company NameLast Price (Rs.)Chg (Rs./%)Sales TurnOverVolume
Remedium Lifecare2079.5052.95(2.61)13.721586.00
Nureca Ltd.425.5046.70(12.33)203.74292341.00
Kemp & Company824.5035.15(4.45)2527.1242.00
Thacker & Co398.9518.90(4.97)152.8318.00
Brand Concepts302.3515.60(5.44)17.3218535.00
More>
KEY PERSONNEL & ADDRESS
Chairman
Swapnil Jatinbhai Shah
Managing Director
Arpit Shah
Registered Office :
1101 To 1103, South Tower,One 42, B/h Ashok Vatika, Nr. Jayantilal Park,Brts, Ambli Bopal Road, Ahmedabad,
Gujarat-380054 .
Phone :
079-29999857  
E-mail :
cs@remuspharma.com
URL
www.remuspharma.com
 
News On REMUS
02/06/2023
Outcome of Board Meeting
02/06/2023
General Announcement
30/05/2023
Outcome of Board Meeting
16/05/2023
Remus Pharmaceuticals coming w...
More >
Financials
QUARTERLY ()
Net Profit( Rs . In Mn)
Gross Profit( Rs . In Mn)
Operating Profit( Rs . In Mn)
Net Sales( Rs .In Mn)
More>
MF Holding Details
Scheme NameMkt value (In Cr.)
No Records Present